Endpoints News ٢٥ نوفمبر ٢٠٢٥ CMS unveils IRA prices for Ozempic, Wegovy and other drugs from second round
Endpoints News ٢٥ نوفمبر ٢٠٢٥ Pharma faces deadline to bring IRA fight to Supreme Court as first set of negotiated prices looms
Endpoints News ٢٥ نوفمبر ٢٠٢٥ FDA OKs Sarepta study of new immune suppression approach with Elevidys; Gilead buys preclinical TREX1 program
Endpoints News ٢٥ نوفمبر ٢٠٢٥ Novo Nordisk’s amycretin cuts body weight, blood sugar in Phase 2 diabetes trial
Endpoints News ٢٥ نوفمبر ٢٠٢٥ Novartis was the sole bidder in $12B deal to buy Avidity #Avidity Biosciences #buy Avidity
Endpoints News ٢٤ نوفمبر ٢٠٢٥ FDA's Pazdur is said to raise questions about commissioners actions, new voucher #commissioners actions #raise questions
Endpoints News ٢٤ نوفمبر ٢٠٢٥ UK-US drug pricing deal could come as early as this week, sources say #told Endpoints #UK-US drug
Endpoints News ٢٤ نوفمبر ٢٠٢٥ #ASH25: Kelonia’s first in vivo CAR-T data; Lilly, J&J and Novartis spell out Phase 3 wins #American Society #wins Late-breaking
Endpoints News ٢٤ نوفمبر ٢٠٢٥ J&J’s tau-targeting antibody fails Phase 2 Alzheimer's study #fails Phase #Alzheimer study
Endpoints News ٢٤ نوفمبر ٢٠٢٥ Kelun's TROP2 ADC plus Keytruda improves outcomes in first-line lung cancer #first-line lung #lung cancer
Endpoints News ٢٤ نوفمبر ٢٠٢٥ Sarepta to pay $200M milestone to Arrowhead; Enlivex reports osteoarthritis data #Clearside Biomedical #MindImmune Therapeutics
Endpoints News ٢٤ نوفمبر ٢٠٢٥ Biogen pens I&I deal with new Versant macrocycle developer Dayra Therapeutics #Versant Ventures’ #Dayra Therapeutics
Endpoints News ٢٤ نوفمبر ٢٠٢٥ Bayer’s stock rallies as next-gen blood thinner beats the odds with Phase 3 win #win Bayer #high-profile failures
Endpoints News ٢٤ نوفمبر ٢٠٢٥ Novo Nordisk's semaglutide misses in closely-watched Alzheimer’s trials #Novo Nordisk #closely-watched Alzheimer
Endpoints News ٢٤ نوفمبر ٢٠٢٥ Craig Crews, Mikael Dolsten raise $32M for Quarry Thera #Mikael Dolsten #Quarry Thera